Results 311 to 320 of about 138,544 (375)
Safety of Proton Pump Inhibitor in Paediatrics: A Study Based on EudraVigilance Data
ABSTRACT Background and Objectives Despite limited paediatric approvals, the use of proton pump inhibitors (PPIs) among children has increased in recent years, and concerns have arisen about their safety, including the risk of allergies. To provide additional evidence on the paediatric safety of PPIs, we performed a study on suspected adverse drug ...
Greta Santi Laurini+3 more
wiley +1 more source
Clinical characteristics and risk factors for escalation to anaphylaxis from non-severe drug hypersensitivity reaction. [PDF]
Rhyou HI+17 more
europepmc +1 more source
Abstract Background Immune checkpoint inhibitors can be coadministered as a fixed‐ratio combination (FRC) or administered as sequential infusions (ASI). Two randomized, open‐label trials compared nivolumab + ipilimumab as a FRC versus ASI in patients with melanoma or renal cell carcinoma.
Alexander M. Menzies+19 more
wiley +1 more source
Possible recurrence of neuromuscular block following balloon dilation for bronchial stenosis in a young patient after bilateral lung transplantation: A case report. [PDF]
Ishihara T, Ito N, Uchida K.
europepmc +1 more source
Cost‐Effectiveness of Ferritin Screening Thresholds for Iron Deficiency in Reproductive‐Age Women
ABSTRACT Iron deficiency (ID) is a top five leading cause of disability‐adjusted life‐years in women of reproductive age around the world. Despite its enormous health burden, no screening guidelines exist for the detection and treatment of ID in women of reproductive age.
Daniel Wang+7 more
wiley +1 more source
Omega-5-Gliadin Allergy and Cofactors Leading to Anaphylaxis: A Case Report. [PDF]
Le Bon Chami B+4 more
europepmc +1 more source
ABSTRACT Managing adult‐onset Still's disease complicated by severe hepatitis requires vigilant monitoring and adaptable therapeutic strategies. Standard treatments such as tocilizumab and rituximab can cause adverse reactions or lose efficacy. The interplay of systemic inflammation and liver involvement highlights the need for ongoing research to find
Majed Ali+3 more
wiley +1 more source
Omalizumab pretreatment in a case of pediatric carboplatin desensitization. [PDF]
Brozyna JR+4 more
europepmc +1 more source